Clinical Trial: GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis.

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889662) titled 'GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis.' on Feb. 06.

Brief Summary: This study aims to answer multiple unsolved questions in the field of arrhythmic myocarditis.

* Improving the diagnostic work-up. While endomyocardial biopsy (EMB) and cardiac magnetic resonance (CMR) constitute the gold standard diagnostic techniques for myocarditis, the role of genetic testing is still unclear. Identifying the subset of patients with CGVs, will contribute to justifying the application of genetic testing in myocarditis.

* Generating models for risk prediction. Outcomes and arrhythmic risk...